年 11 月 22 日，修正药业集团北京科技创新中心正式落成，在京隆重举办了揭牌仪式。 On November 22 , 2014, Beijing Science and Technology Innovation Center of Amendment Pharmaceutical Group was officially completed, and the unveiling ceremony was held in Beijing. Amendment Chairman Xiu Gui, General Manager of Xiuyuan Pharmaceutical Group, Executive Vice President Gao Lu, Vice President Wang Zhiguang, and relevant persons in charge of the Science and Technology Innovation Center attended the opening ceremony. It is reported that the completed Beijing Science and Technology Innovation Center will continue to use the successful experience of the past technology innovation center of the pharmaceutical industry. Based on Beijing and facing the country, it will create a new model of new product development in the domestic market and start a powerful engine for the future development of the pharmaceutical industry.
(From the left of the figure are Vice President Wang Zhiguang of Amendment Pharmaceutical Group, Chairman of Xiu Yangui, General Manager of Xiu Yuan, and Vice President Gao Lu)
Beijing Science and Technology Innovation Center is a powerful engine and accelerator for the development of new products for the pharmaceutical industry. This core team rooted in the large domestic market will have a keen sense of insight into the consumer's unsatisfied consumer needs, and will cooperate with other functional departments The close cooperation has led to the development of new products with Chinese characteristics, modified characteristics, and suitable for use by Chinese consumers.
(Amended the group photo of the leaders of the Pharmaceutical Group and some members of the Science and Technology Innovation Center team)
Different from the general R & D center, this independent space in the detached office building of Beijing Correction Medical Technology Industry Base is a place to inspire creativity. —— 这就是修正药业科技创新中心。 The large hall, transparent light on both sides, bright bright yellow color decoration, movable seats, digital results report hall, fully open working environment, all reflect the relaxed and free, unconstrained working state, compact and A united work atmosphere - this is the Science and Technology Innovation Center of the Pharmaceutical Industry.
OTC 品牌：斯达舒、肺宁颗粒、唯达宁、消糜栓、感愈胶囊等。 The current family members of Amend Pharmaceuticals include OTC brands familiar to consumers over-the-counter : Olympus Starc, Feining Granules, Weidain, Xiaomi Suppository, Ganyu Capsules, etc. IMS 市场监测数据已经成为了市场的领导品牌，要挖掘其增长的潜力，除了通过传统方式加大营销力度外，更重要的是对新产品开发与技术革新。 These brands have become the market's leading brands according to IMS market monitoring data. To tap their growth potential, in addition to increasing marketing efforts through traditional methods, it is more important to develop new products and technological innovation.
(Amended the leaders of the Pharmaceutical Group and some employees in Beijing took a group photo in front of the Science and Technology Innovation Center)
Chairman Xiu Guigui said at the unveiling ceremony that the launch of a new drug is inseparable from the support of science and technology and requires the collaborative innovation of various departments. This is the profound experience of the amending pharmaceutical industry in its continuous progress. The innovation research and development center should make full use of Beijing's geographical, technological, and cultural advantages to realize the transfer from technology to products. It will truly serve the people and will also become a new growth point for enterprises. In recent years, the strategy for the development of large health industries has been amended. The development of these industries is supported by science and technology. From the concept of scientific development and the requirements of sustainable development, we must integrate resources through innovation drive, and accelerate the pace of new product development through R & D and industrialization. This is also an important choice for amending the pharmaceutical industry to face society, economic development, and overseas.